Urvy Shah: High-Fiber Dietary Intervention in Precursor Plasma Cell Disorders
Urvy Shah shared a post by MSKCC on X, adding:
“This project has been a wonderful collaboration and team science including Marcel van den Brink, van den Brink Lab, Alexandr Lesokhin, Saad Usmani, Neil Iyengar and mouse data from Cellular Immune lab Laura Cogrossi, MSKCC and many others.
Look forward to presenting latest updates.”
Quoting MSKCC’s post:
“New results were presented at ASH by lead researcher Urvi Shah from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression to multiple myeloma.
Learn more about this research.”
Authors: Urvi A. Shah, Laura Lucia Cogrossi, Andriy Derkach, Francesca Castro, Teng Fei, Susan DeWolf, Juan-Jose Garces, Anna Policastro, Matteo Grioni, Sofia Sisti, Blaslov Jenna, Peter Adintori, Kinga K. Hosszu, Devin McAvoy, Mirae Baichoo, Justin Cross, Aishwarya Anuraj, Charlotte Pohl, Ruben Ramos, Jenny Paredes Sanchez, Brianna Gipson, Kylee H Maclachlan, Ana Gradissimo, Leonardo Boiocchi, Richard Koche, Ronan Chaligne, Torin Block, Neha Korde, Carlyn Rose Tan, Malin Hultcrantz, Hani Hassoun, Gunjan L. Shah, Michael Scordo, Oscar B Lahoud, David J. Chung, Heather J. Landau, Jonathan U. Peled, Nicola ClementiMarta Chesi, P. Leif Bergsagel, Sham Mailankody, Michael Pollak, Anita D’Souza, Ola LandgrenSusan Chimonas, Sergio Giralt, Saad Z. Usmani, Neil M. Iyengar, Alexander M. Lesokhin, Matteo Bellone, Marcel R.M. van den Brink,
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023